Graves' disease
RecruitingLong-Term Study of Imeroprubart in Adults With Graves' Disease
- Disease:Graves' disease
- Substances:IMEROPRUBART
Italy- Participants:18–64 years · 65+ years
- Substances:IMEROPRUBART
- Sponsor:Immunovant Sciences GmbH
Rare diseases
Investigational molecules
Locations
Back to Italy885 clinical trials in Bologna, Italy across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Immune Thrombocytopenia and various forms of blood cancers including Acute Myeloid Leukemia and Multiple Myeloma. These trials aim to evaluate novel therapeutic approaches and combination treatments.
Studies include evaluation of new compounds and their safety profiles in treating various blood-related conditions.
Comprehensive studies on inflammatory bowel conditions, focusing on Crohn's Disease and Ulcerative Colitis. Research aims to develop more effective treatments for patients with moderate to severe disease activity.
Trials evaluate both induction therapy and long-term treatment options for gastrointestinal conditions.
Investigation of treatments for sleep disorders including Narcolepsy and Idiopathic Hypersomnia, along with research into Chronic Inflammatory Demyelinating Polyneuropathy.
Focus on developing safer and more effective therapies for various neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.